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Abstract: Oral cancer represents a health burden worldwide with approximate 275,000 new 
cases diagnosed annually. Its poor prognosis is due to local tumor invasion and frequent 
lymph node metastasis. Better understanding and development of novel treatments and 
chemo-preventive approaches for the preventive and therapeutic intervention of this type of 
cancer are necessary. Recent development of dietary polyphenols as cancer preventives and 
therapeutic agents is of great interest due to their antioxidant and anti-carcinogenic activities. 
Polyphenols may inhibit carcinogenesis in the stage of initiation, promotion, or progression. 
In particular, dietary polyphenols decrease incidence of carcinomas and exert protection 
against oral cancer by induction of cell death and inhibition of tumor growth, invasion, and 
metastasis. In this review, we discuss current progress of dietary polyphenols against oral 
cancers in vitro, in vivo, and at population levels. 
Keywords: dietary polyphenols; tea polyphenols; (−)-epigallocatechin-3-gallate; oral cancer; 
cancer prevention; cancer therapy; cell death; cell growth; cell migration and invasion 
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APP: Amyloid precursor protein 
OPEN ACCESS 
Nutrients 2013, 5 2174 
 
 
BaP: Benzo[a]pyrene 
BTE: Black tea polyphenol extracts 
C: (+)-Catechin 
CDDP: cis-Platinum(II) diammine dichloride 
CG: (−)-Catechin gallate  
DMBA: 7,12-Dimethylbenz (a) anthracene 
EC: (−)-Epicatechin 
ECG: (−)-Epicatechin gallae 
EGC: (−)-Gallocatechin 
EGCG: Epigallocatechin gallate 
EGFR: Epidermal growth factor receptor 
EMT: Epithelial to mesenchymal transition 
ERK: Extracellular regulated kinase 
FAK: Focal adhesion kinase 
GTE: Green tea extract 
GTPs: Green tea polyphenols 
HBP: Hamster buccal pouch 
MBN: N-methyl-N-benzylnitrosamine 
MDR: Multidrug resistance 
MMP-2: Matrix metalloproteinase-2 
MMP-9: Matrix metalloproteinase-9 
MMPs: Matrix metalloproteinases 
OPL: Oral premalignant lesions 
ROS: Reactive oxygen species 
Stat 3: Signal transducer and activator of transcription 3 
SCCHN: Squamous cell carcinoma of the head and neck 
TF-2A: Theaflavin-3-gallate 
TF-2B: Theaflavin-3′-gallate 
TF-3: Theaflavin-3 and 30-digallate 
TPs: Tea polyphenols 
uPA: Urokinase-type plasminogen activator 
1. Introduction 
1.1. Oral Cancer 
Oral cancer is a serious and growing issue in many countries [1,2]. Oral and pharyngeal cancer, 
grouped together, is the sixth most common cancer in the world. The annual estimated incidence of oral 
cancer is about 275,000; two-thirds of these cases occurred in developing countries. Both incidence and 
mortality rate are higher in men than women. The variety of incidence and mortality rate among 
countries may due to distinct risk profiles, and availability and accessibility of health services. In the 
areas with high incidence rate such as Sri Lanka, India, Pakistan, and Bangladesh, oral cancer is the most 
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common cancer in men, and may contribute up to 25% of all new cases of cancer [3]. Most oral 
malignancies are squamous cell carcinomas and the risk of developing oral cancer has been shown to 
increase with age [3]. Tobacco use including smokeless tobacco and excessive alcohol consumption are 
estimated to account for about 90% of oral cancers [3]. The 58th World Health Assembly Resolution on 
Cancer Prevention and Control in year of 2005 urged Member States to develop and reinforce national 
cancer control program, prioritizing preventable tumors and risk factor intervention. 
1.2. Polyphenols 
Polyphenols represent the largest group of phytochemicals found in plants, particularly in fruits, 
seeds, and leaves. These compounds exhibit health benefits through complementing and adding to the 
functions of antioxidant vitamins and enzymes as defense against oxidative stress caused by excess 
reactive oxygen species (ROS). Dietary polyphenols have been paid attention due to their benefits on 
human health. High intake of fruits, vegetables, and whole grains, which are rich in polyphenols, has 
been linked to lowered risks of many diseases including cancer, cardiovascular disease, chronic 
inflammation, and neurodegenerative diseases [4]. In particular, the property of dietary polyphenols 
against tumorigenesis is attractive to the researchers and health workers. The action of polyphenols has 
been investigated in various cancers including lung, skin, oral cavity, ovarian, esophagus, stomach, 
liver, pancreas, endometrial, thyroid, testicular bladder, small intestine, colon, urinary tract, and 
prostate [5,6]. It has been demonstrated that polyphenols exhibit anti-cancer property by interfering with 
molecular events involved in initiation, promotion, and progression stages [7]. 
Chemoprevention is a promising approach for controlling transformation of premalignant or 
potentially malignant lesions to invasive cancer. Polyphenols has been used as a chemopreventive agent 
to modulate oral carcinogenesis process. In this review, we provide an overview of protective effects of 
dietary polyphenols against oral cancers. 
2. Classification and Resources of Dietary Polyphenols 
Dietary polyphenols constitute one of the most numerous and widely distributed groups of natural 
products in the plant kingdom. Fruits, vegetables, whole grains, and beverages such as tea, chocolate, 
and wine are rich sources of polyphenols. More than 8000 phenolic structures are currently known, and 
majority of plants carry at least some of polyphenols. Although polyphenols are chemically characterized 
as compounds with phenolic structural features, this group of natural products is highly diverse. 
2.1. Phenolic Acids 
Phenolic acids are abundant in food and may account for about one third of phenolic compounds in 
our diet. They can be further divided into two main types: hydroxybenzoic acid and hydroxycinnamic 
acid derivatives based on C1–C6 and C3–C6 backbones. Caffeic acid and ferulic acid are main 
hydroxycinnamic acid derivatives. Caffeic acid, which can be found in many fruits such as apple, plum, 
tomato, and grape, occurs mainly as an ester with quinic acid called chlorogenic acid (5-caffeoylquinic 
acid). Chlorogenic acid is a key substrate for enzyme oxidation. Ferulic acid, which is linked through 
ester bonds to hemicellulose of the cell wall, is found in grains and seeds. Curcumin, another 
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hydroxycinnamic acid derivative, is used for food preservation with yellow pigment in turmeric and 
mustard [8]. 
2.2. Flavonoids 
Flavonoids contain the C6–C3–C6 general structural backbone in which the two C6 units (Rings A 
and B) are of phenolic nature. These compounds constitute a very diverse group of secondary plant 
metabolites and they are divided into sub-groups including flavonols, flavones, flavanones, flavanonols, 
flavanols, isoflavonoids, anthocyanidins, and proanthocyanidins [9–11]. Flavones and their 3-hydroxy 
derivative flavonols are the largest subgroup among all polyphenols. Quercetin is common flavonol 
present in many fruits, vegetables, and beverages [12]. Flavanones and their 3-hydroxy derivatives 
flavanonols have a large number of substituted derivatives [13]. Flavanols or flavan-3-ols are commonly 
called catechins, which are abundant in tea, red wine, and chocolate. (+)-Catechin and (−)-epicatechin 
are two isomers found in food plants, particularly in skins of grape, apple, and blueberry [14]. 
Anthocyanidins are principal components of red, blue, and purple pigments of flower petals, fruits, and 
vegetables, and varieties of grains, such as black rice. 90% of anthocyanins are based on cyanidin, 
delphinidin, and pelargonidin and their methylated derivatives [15]. 
2.3. Resveratrol, Lignans and Ellagic Acid 
Resveratrol is a plant-derived polyphenolic phytoalexin produced by enzyme stilbene synthase. It is 
present in grape, red wine and peanut [16]. Lignans exist in the bound forms in flax, sesame, and many 
grains. Ellagic acid, a dimer of gallic acid, can be found in free forms in different plants [17]. 
3. Dietary Intake of Phenolic Compounds 
Because polyphenols represent a wide variety of diverse structures from different subclasses, it is 
difficult to estimate total polyphenol content. It had been reported that main polyphenol dietary sources 
are fruits and beverages (fruit juice, wine, tea, coffee, chocolate, and beer) and, to a lesser extent, 
vegetables, dry legumes, and cereals. The total intake is ~1 g/day [1]. The mean intake of polyphenols 
was 863 ± 415 mg/day based on 48 hour dietary recalls in 2007 [18]. Phenolic acids comprised dominant 
group of polyphenols (75% of total intake) followed by proanthocyanidins (14%), anthocyanidins, and 
other flavonoids (10%). Coffees and cereals are key contributors to the total polyphenol intake especially 
to phenolic acids. Berries and their products are main sources for anthocyanidins, ellagitannins, and 
proanthocyanidins, while fruits are sources for flavonols, flavones, and flavanones [18]. Pierre et al. [19] 
generated a database of polyphenol content of fruits and vegetables and then evaluated polyphenol 
intake through fruit and vegetable consumption in France. Based on fruit consumption data, apples and 
strawberries are main sources of polyphenols in French diet, whereas potatoes, lettuces, and onions are 
the most important vegetable sources. Total polyphenol intake from fruits is about three times higher 
than from vegetables. The calculation of polyphenol intake showed that apples and potatoes provide 
~47% of the total polyphenol intake from fruit and vegetables in French diet [19]. Overall, the consumption 
of dietary polyphenols can vary significantly among individual due to different dietary habits. 
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4. Bioavailability of Phenolic Compounds 
The bioavailability of phenolics is low and the values of urinary excretion of intake range from 0.3% 
for anthocyanins to 43% for isoflavones [20]. The absorption of food phenolics is determined primarily 
by chemical structure, which depends on degree of glycosylation and acylation, basic structure (i.e., 
benzene or flavone derivatives), conjugation with other phenolics, molecular size, polymerization, and 
solubility [21]. Maximum concentration in plasma rarely exceeds 1 mM after the consumption of 
10–100 mg of a single phenolic compound [22]. It has been reported that a micromolar concentration of 
quercetin, catechins, isoflavones in blood was reached after a meal comprising onions, red wine, and 
soy, respectively [1,23,24]. 
5. Dietary Polyphenol and Oral Cancer Prevention 
Many studies have been carried out to investigate inhibitory effect of plant polyphenols on 
tumorigenesis. In these studies, polyphenols-mediated oncogenes, tumor suppressor genes, cell cycle, 
apoptosis, angiogenesis, and related signal transduction pathways are emphasized. In this review, we 
only discuss studies related to oral cancer. 
5.1. In Vitro Studies 
A variety of in vitro studies demonstrated multiple outcomes as mechanisms of polyphenols. Major 
in vitro studies that show the targets/outcomes of chemoprevention by polyphenols are summarized in 
Table 1 and discussed below. 
5.1.1. EGCG and other Green Tea Polyphenols 
Tea is listed to the second only to water in worldwide popularity as a beverage. Green tea was shown 
to be associated with many health benefits including prevention of cancer and heart disease for 
decades [2]. Major constitutions of green tea are (−)-epigallocatechin gallate (EGCG), (−)-gallocatechin 
(EGC), (−)-epicatechin gallae (ECG), (−)-catechin gallate (CG), (−)-epicatechin (EC), and (+)-catechin 
(C) [25]. Numerous in vitro studies have shown capability of green tea polyphenols especially EGCG in 
reduction of cell growth, induction of apoptosis, and inhibition of angiogenesis in oral cancer cell 
lines [26]. EGCG acts as a pro-oxidant and tumor cells are more vulnerable to oxidative forces than 
normal cells. Avi et al. [27] reported that EGCG effectively inhibited cancer cell growth in cells derived 
from oral dysplastic leukoplakia and squamous cell carcinoma. Jeffrey et al. [28] have also reported that 
the anti-proliferative effect of green tea polyphenols and EGCG, was more sensitive in oral cancer cell 
lines (CAL27, HSC-2, and HSG1) than normal fibroblasts (GN56 and HGF-1). EGCG treatment caused 
generation of hydrogen peroxide (H2O2), one of major ROS. The results from assessment of cytotoxicity 
of a green tea polyphenol CG in cell lines derived from human oral cavity indicated that CG selectively 
induced cell death in favor of cancer cells [29]. Further study indicated that cytotoxicity of CG in cancer 
cells was due to its capability of inducing H2O2 generation. 
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Table 1. Summary of in vitro studies of dietary polyphenols against oral cancer. 
Compound Cell line(s) Treatment dose/duration Targets/Outcome (Reference) 
BTEs  SCC-4 10–40 μg/mL, 24 h Reducing MMP-2 and uPA [30] 
Cranberry polyphenols KB and CAL27 200 µg/mL, 48 h Inhibiting oral cancer cells [31] 
CG and other TPs S-G, CAL27, and HSG  25–200 µM, up to 72 h Inducing cell death and inhibiting proliferation [29] 
DMF SCC-9 0.1–100 µM, up to 48 h Inhibiting CYP1B1/1A1 function [32] 
ECG and other TPs HSC-2 and HGF-2 50–500 µM, up to 72 h Inhibiting cell proliferation and inducing apoptosis [33] 
EGCG CAL-27 25–100 μM, up to 48 h Suppressing p-EGFR and MMP-2 [34] 
EGCG SCC-9 5–20 µM, up to 24 h Reducing expressions of MMP-2, MMP-9, uPA, p-FAK, Src, snail-1, and 
vimentin [35] 
EGCG Tu177, Tu212, Tu686 , and 686LN 30 µM, up to 72 h Inducing cell cycle arrest and apoptosis via p53 [36] 
EGCG HSC3, HSC4, SCC9, SCC25 5–50 µM, up to 5 days Enhancing RECK expression, inhibiting MMP-2 and MMP-9 expression [37] 
EGCG OC2 5–60 µM, 24 h Inhibiting cell invasion and migration [38] 
EGCG OSC2, G6, S2, and S5 50 µM, up to 72 h Regulating p21WAF1, p57 modulating epithelial cell differentiation, or 
apoptosis [39,40] 
EGCG OECM-1 1–20 µM, 24 h Inhibiting APP expression [26] 
EGCG NS-SV-AC, NSSV, OSC-2, and OSC-4 12.5–50 µM, 24 h Protecting cells from chemical or irradiation-induced damage [41] 
EGCG and curcumin MSK Leuk1 50 µM, 5 days Cell growth [27] 
EGCG, ECG, EGC, 
resveratrol, and quercetin 
SCC-25 50–200 µM, up to 72 h Cell growth [42,43] 
GTE and EGCG CAL-27, SCC-25, and KB 50–200 µM, up to 72 h Inhibiting cell growth via EGFR and Notch signaling [44] 
Polyphenon-E and 
Polyphenon-B 
CAL-27  25–400 µg/mL, 24 h Inducting ROS generation and Bcl-2/Bax-mediated apoptosis [45] 
GTPs and EGCG OSC2 50–200 µM, up to 72 h Inducing apoptosis, inhibiting cell growth [46–48] 
Methoxylated flavones SCC-9 25 µM, 24 h Inhibiting CYP1B1 mRNA expression [49] 
MT SCC-61 and OSCC-3 0.05–1000 µg/mL, 48 h Inhibiting oral cancer proliferation [50] 
150 of natural and 
synthetic polyphenols  
HSC-2, HSG Various, up to 48 h Cytotoxic activity [51,52] 
Quercetin SCC-9 cells 0–200 µM, up to 72 h Inducing cell death [53] 
Quercetin, resveratrol, 
and ellagic acid 
Oral tissue 25 µM, 24 h Inhibiting BaP-DNA binding and oxidization [54] 
Sasa senanensis Rehder 
leaves extracts 
HSC-2 0.22% and 0.18%, 24 h Protecting cells from ultraviolet -induced injury [55] 
TF-2A and TF-2B  HSC-2 and CAL27 100–500 µM, up to 24 h Prooxidant action [56,57] 
TPs Tca8113 25–200 µM, up to 72 h Inhibiting cell proliferation and hTERT expression [58,59] 
Tea extracts and EGCG CAL27, HSC-2, HSG, S-G, GN56, and HGF-1 0–200 µg/mL, up to 72 h Oxidative stress-induced cell death [28] 
TPs and EGCG KB-A-1 0.2 µg/mL, 24 h Enhancing intracellular concentration of DOX and modulating MDR [60] 
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Elattar et al. [42] evaluated the effect of three major tea constituents, EGCG, ECG, and EGC on the 
cell growth and DNA synthesis of human oral squamous carcinoma cell line SCC-25. These three 
compounds caused dose-dependent inhibition in both cell growth and DNA synthesis [42]. A study by 
Muneyuki et al. [61,62] has also demonstrated that treatment with EGCG induced cell cycle arrest at G1 
phase due to decrease of cyclin D1 expression, increases of p21Cip1 and p27Kip1 expression, and 
reduction of hyper-phosphorylated form of pRB. Liu et al. [44] have found that green tea extract and 
EGCG inhibited cell growth in three squamous cell lines (CAL-27, SCC-25, and KB) via S and G2/M 
phase cell cycle arrest. Results from Pathway Array assessment of 107 proteins indicated that major 
signaling pathways affected by GTE and EGCG were EGFR and Notch, which in turn affected cell cycle 
related networks [44]. 
Epithelial to mesenchymal transition (EMT) is critical for the progression, invasion, and metastasis of 
epithelial tumorigenesis. Molecular evidences associated with the anti-metastatic effect of green tea 
polyphenols and EGCG have been established. EGCG treatment in oral squamous SCC-9 cells blocked 
cell invasion via a reduced expression of matrix metalloproteinase-2 (MMP-2) and urokinase type 
plasminogen activator (uPA) [35]. EGCG exerted an inhibitory effect on cell migration, motility spread, 
and adhesion. EGCG inhibited phospho-focal adhesion kinase (p-FAK), p-Src, snail-1, and vimentin, 
indicating the anti-EMT effect of EGCG in oral squamous cell carcinoma [35]. RECK is a tumor 
suppressor gene that negatively regulates MMPs and inhibits tumor invasion, angiogenesis, and 
metastasis. Kato et al. [37] have reported that treatment of oral cancer cells with EGCG partially 
reversed the hypermethylation status of the RECK gene and significantly enhanced the expression level 
of RECK mRNA, leading to reduced MMP-2 and MMP-9 expressions. 
In addition to its capacity against tumorigenesis, EGCG also synergistically cooperated with other 
pharmaceutical inhibitors, such as gefitinib, an EGFR inhibitor. Combined treatment of gefitinib and 
EGCG synergistically inhibited invasion and migration of CAL-27 cells [34]. EGCG sensitized CAL-27 
cells to gefitinib-suppressed phosphorylation of EGFR [34]. Another study has also showed that 
simultaneous treatment with EGCG and erlotinib, an inhibitor of EGFR-tyrosine kinase, strongly 
induced cell cycle arrest and apoptosis via p53-dependent induction of p21, p27, and Bim, and 
p53-dependent inhibition of NF-κB and its antiapoptotic target, Bcl-2 in squamous cell carcinoma of the 
head and neck cells (SCCHN) [36]. 
Resistance of malignant tumors to chemotherapeutic agents is a major cause of treatment failure in 
patients with cancers. Wei et al. [60] demonstrated that tea polyphenols (TPs) and EGCG were 
modulators of multidrug resistance (MDR) that could influence activity of anti-neoplastic drug, 
doxorubicin (DOX). DOX, the most effective broad spectrum antitumor antibiotics, its application in 
clinic may be limited due to MDR. In fact, TPs and EGCG enhanced the intracellular concentration of 
DOX by 4.4 and 2.2 times, respectively. Overexpression of amyloid precursor protein (APP) is a 
biomarker to monitor OSCC prognosis. Shun-Yao et al. [26] have demonstrated that EGCG might 
diminish oral carcinogenesis by down-regulating APP in OECM-1 oral squamous carcinoma cells. 
Babich et al. [58] and Yao et al. [59] have shown that TPs disabled telomerase activity and thereby 
terminated unlimited cancer cell proliferation in cancerous Tca8113 cells, giving additional insight into 
the inhibitory potential of tea ingredients in the treatment of resistant tumors. 
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5.1.2. Black Tea Polyphenols 
The typical composition of black tea beverage contains 8% of catechins, 10% of flavonol glycosides, 
12% of theaflavins, and 70% of thearubigens [63]. Among these components, theaflavins are generally 
considered to be most effective against carcinogenesis. Schuck et al. [56] have shown that treatments of 
theaflavin-3 and 30-digallate (TF-3) inhibited more cell growth in HSC-2 cancer cells than normal 
GN46 fibroblasts. TF-3 could generate ROS, leading to apoptotic cell death in HSC-2 cells, but not in 
GN46 fibroblasts. TF-3 may function as a prooxidant to induce oxidative stress, thereby accounting for 
their cytotoxicity to cancerous cells [56]. 
The responses of human gingival fibroblasts and carcinoma cells derived from the tongue to 
theaflavin-3-gallate (TF-2A) and theaflavin-3′-gallate (TF-2B), two polyphenols in black tea, have been 
compared [57]. It was reported that TF-2A and TF-2B acted as pro-oxidants to induce cell apoptosis in 
carcinoma cells, but not in normal fibroblasts [57]. ROS played a key role and that Bcl-2/Bax was 
involved in mitochondrial mediated apoptosis by dissipating mitochondrial transmembrane potential 
(ΔΨm) and activating caspase-3 [46]. Chang et al. [30] have demonstrated that inhibition of black tea 
polyphenol extracts (BTE) on cell invasion in human tongue squamous carcinoma SCC-4 cells was 
through reduced activities of MMP-2 and u-PA, up-regulated E-cadherin, and down-regulated snail 
and vimentin. 
5.1.3. Other Dietary Polyphenols 
Besides green and black tea polyphenols, many other dietary polyphenols are associated with oral 
cancer-preventive activities. A total of 150 chemically defined natural and synthetic polyphenols 
(flavonoids, dibenzoylmethanes, dihydrostilbenes, dihydrophenanthrenes, and 3-phenylchromen-4-ones) 
were investigated for cytotoxic activity against normal, tumor, and HIV-infected cells [51]. Similar to 
tea polyphenols, these polyphenols selectively caused more cell death in cancer cells than that in normal 
cells [51]. 
Resveratrol and quercetin are polyphenols that have been detected in significant amounts in green 
vegetables, citrus fruits, and red grape wines. Resveratrol induced significant dose-dependent inhibition 
of DNA synthesis and related cell growth while quercetin exerted a biphasic effect: stimulation at 1 μM 
and 10 μM, and minimal inhibition at 100 mM in cell growth and DNA synthesis [43]. 
Haghiac et al. [53] reported that quercetin induced necrosis at treatment time of 24 h and 48 h, whereas 
at 72 hours cells underwent apoptosis, correlating with caspase-3 activation. Study on cell cycle 
distribution showed that quercetin induced S-phase arrest with an inhibition of thymidylate synthase, a 
key enzyme of S phase. Walle et al. [54] have tested quercetin, resveratrol, and ellagic acid in a 
bioengineered construct of the multilayered stratified human oral epithelial tissue. The results showed 
that flavonoids, 5,7-dimethoxyflavone (5,7-DMF) and 3′,4′-dimethoxyflavone (3′,4′-DMF) were able to 
inhibit benzo[a]pyrene (BaP)-induced CYP1A1 and 1B1 activities [32]. The results from screening of 
19 methoxylated falvones in human squamouse cell carcinoma SCC-9 cell showed that 4 out  
of 19 compounds including 3′,4′-DMF, 5,7,4′-trimethoxyflavone, 7,3′-dimethoxyflavone, and 
7,4′-dimethoxyflavone were found to be potent inhibitors of CYP1B1 mRNA expression [49]. 
Curcumin and quercetin, unmethylated polyphenols, were also potent inhibitors [49]. 
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5.2. Animal Studies 
At present, there are a limited number of animal studies showing the usefulness of dietary 
polyphenols on oral cancer chemoprevention by modulating cell proliferation, cell survival, tumor 
infiltration, angiogenesis, and apoptosis. Important work on this direction are discussed below and 
summarized in Table 2. 
7,12-dimethylbenz (a) anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis 
model has been extensively employed to investigate the chemopreventive effectiveness of dietary 
agents. Ning et al. [64] has shown that tea preparations could inhibit DMBA-induced oral carcinogenesis 
in hamsters effectively due to their capacities against DNA damage and suppression of cell proliferation. 
Chandra et al. [65] and Mohan et al. [66] observed that inhibition of HBP carcinomas by polyphenon-E 
and -B was associated with a significant decrease in phase I enzymes, modulation of lipid peroxidation 
and enhanced antioxidant and phase II enzyme activities. Administration of polyphenon-E and -B to 
DMBA-treated hamsters significantly decreased lipid peroxidation and enhanced GSH level, 
GSH/GSSG ratio, and activities of GSH-dependent enzymes [66,67]. Polyphenon-B was more effective 
in inhibiting HBP carcinogenesis than polyphenon-E by enhancing the antioxidant status [67]. Dietary 
supplementation of polyphenon B could exert protection against DMBA-induced genotoxicity and 
oxidative stress by augmenting bone marrow antioxidant defense mechanisms [68]. 
Moreover, the inhibitory effects of polyphenon-B on HBP carcinogenesis has been associated to a 
decrease in cell proliferation and an enhancement in apoptosis, as evidenced by down-regulations of 
PCNA, NF-κB, p53, and Bcl-2 and upregulation of Bax, Fas, and caspase 3 [69]. Letchoumy et al. [70] 
found that administration of polyphenon-B and BTF-35 significantly decreased tumorigenesis induced 
by DMBA by reduced expressions of p21, cyclin D1, GST-P, NF-κB, cytokeratins, VEGF, and Bcl-2, 
and increased expressions of Bax, cytochrome C, caspase-3, caspase-9, and PARP. 
Other in vivo studies have been undertaken in addition to DMBA-induced HBP carcinogenesis. 
Srinivasan et al. [71] reported that green tea polyphenols (GTPs) administration to rats significantly 
reduced both number and volume of oral squamous cell carcinomas induced by 4-nitroquinoline 1-oxide 
(4-NQO) compared to 4-NQO treatment only. Inhibition of Phase I enzymes (cytochrome b5, cytochrome 
P450, and cytochrome b5 reductase) and induction of Phase II enzymes ((glutathione-S-transferase and 
UDPglucuronyl transferase) by GTPs could be attributed to their protective efficacy against 
tumorigenesis [71]. GTPs reduced oxidant production and increased levels of GSH, PSH, and total  
thiols [72]. Other studies have shown that GTPs administration altered the expression of glycoconjugates 
(hexose, hexosamine, sialicacid, fucose and mucoprotein) and immunological markers (circulating 
immune complex and mast cell density), resulting in regression of oral cancer [73]. In a hamster model 
of N-methyl-N-benzylnitrosamine (MBN)-induced oral carcinogenesis, the incidence of buccal pouch 
carcinomas was significantly reduced when administrated with EGCG [26]. 
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Table 2. Summary of in vivo studies of dietary polyphenols against oral cancer. 
Compound Animal studies Treatment dose, route, and duration Target/Outcome (Reference) 
EGCG Immuno-deficient nude mice 10–20 mg/kg/day, oral gavage, 45 days Inhibition of tumor growth and cell invasion [35] 
EGCG MBN-treated HBP carcinomas 0.2%, drinking water, 9 weeks Decreasing the incidence of carcinomas and APP expression [26] 
EGCG and EGC  Wistar strain rats 200 mg/kg/day, oral gavage, 13 weeks Inhibiting Phase I enzymes to deactivate carcinogen, inducing Phase II 
enzymes to detoxify 4-NQO [71] 
(−)-Gossypol Athymic nude mice 5 and 15 mg/kg/day, intraperitoneal, 
91 days 
Inhibiting tumor growth [74] 
GTPs DMBA-induced oral 
carcinogenesis in golden 
Syrian hamsters 
0.5%–1.5%, drinking water, 15 weeks Inhibiting oral carcinogenesis, protecting from DNA damage and 
suppression of cell proliferation [64] 
GTPs Wistar strain rats 200 mg/kg/day, oral gavage, 30 days Reducing oxidant production and enhancing cellular thiol status to 
mitigate oral cancer and attenuating MC activation [72,73] 
Polyphenon-B DMBA-induced HBP 
carcinogenesis 
0.05% and 0.2%, diet, 14 weeks Decreasing cell proliferation and enhancing apoptosis by downregulating 
PCNA, NF-κB, p53 and Bcl-2 and upregulating Bax, Fas and caspase 3 
expression [69] 
Polyphenon-B and 
BTF-35 
DMBA-induced HBP 
carcinogenesis 
0.05% and 0.2%, diet, 14 weeks Inhibiting oxidative DNA damage and modulating 
xenobiotic-metabolizing enzymes [75] 
Polyphenon-E and 
Polyphenon-B 
DMBA-induced HBP 
carcinogenesis  
0.05%, diet, 18 weeks Inhibiting HBP carcinogenesis and modulating carcinogen-metabolizing 
enzymes and the redox status [65,67,68] 
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5.3. Clinical Studies and Epidemiologic Studies 
Although many laboratory studies have demonstrated that dietary polyphenols exhibit anti-mutagenic 
and anti-carcinogenic effects, intervention trial is the most important approach to elucidate protective 
effects of dietary polyphenols. A number of clinical studies and epidemiologic studies have been 
summarized in Table 3. 
Ning et al. [76] performed the first clinical trial in 1999 to provide direct evidence of the protective 
effect of tea polyphenols against human oral cancer. A double-blind intervention trial was conducted in 
64 patients of both sexes, mostly smokers with oral mucosa leukoplakia (a pre-neoplastic lesion) using a 
mixed green tea product compared to the placebo (using starch and coloring agents with only glycerin) 
for six months. Results showed that oral lesions were significantly reduced in 38% of patients treated 
with green tea mixture compared with 10% of patients in the placebo group. The incidence of 
micronucleated exfoliated oral mucosal cells was significantly lowered in the green tea mixture-treated 
group (5.4/1000 cells) compared to that in control placebo group (11.3/1000 cells). The overall results 
provided a unique opportunity for the investigation of mechanisms of oral cancer prevention by dietary 
polyphenols in humans. Schwartz et al. [77] performed a pilot intervention study using human oral cells 
in three heavy smokers (A10 cigarettes/day) and three nonsmokers (without smoking history) in order to 
evaluate the molecular and cellular effects of administrating green tea total extracts (2000–2500 mg/day). 
The results showed that green tea administration decreased smoking-induced DNA damage and 
inhibited cell growth. This study verified the role of green tea in the prevention of oral cancer in smokers 
by inducing cancer cell growth arrest and apoptosis, a mechanism similar to that observed in cultured 
cells and animal models. 
Tsao et al. [78] performed a phase II randomized, placebo controlled clinical trial of green tea extract 
(GTE) (500, 750, or 1000 mg/m
2
) in patients with high risk oral premalignant lesions (OPL) for  
12 weeks. The OPL clinical response rate was higher in all GTE arms versus placebo but did not reach 
statistical significance. However, the two higher-dose GTE arms (750 and 1000 mg/m
2
) had higher 
response, suggesting dose-response effect of GTE on oral premalignant lesions. Baseline stromal VEGF 
levels correlated with clinical but not histologic response. Other biomarkers including epithelial VEGF, 
p53, Ki-67, cyclin D1, and p16 promoter methylation) were not associated with the outcome. Results 
from this study suggested that GTE might suppress OPLs, in part through reducing angiogenic stimulus 
(stromal VEGF). Another clinic trial study indicated that green tea exhibited protective effects against 
oxidative DNA damage induced by cigarette smoking, leading to delayed lesion progress in patients 
with oral mucosa leukoplakia, demonstrating its protective effects from oral cancer [79]. 
In addition to the preventive effects of green tea, the chemopreventive capacity of other dietary 
polyphenols has also been investigated. Halder et al. [80] have explored the possible benefits of black 
tea administered to 82 patients with oral leukoplakia. The first 15 patients enrolled in this study showed 
a significant decrease in the micronuclei frequency and chromosomal aberrations, which correlated with 
the clinical improvement [80]. 
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Table 3. Summary of epidemiologic and clinical studies of dietary polyphenols against oral cancer. 
Compound Human studies Administration dose, route, duration, and cases Target/Outcome (Reference) 
TPs Study in patients with cigarette 
smoking and oral mucosa 
leukoplakia 
3 g/day. Both oral and topical administration. 6 months. 
59 patients. 
Protection against oxidative damage and DNA 
damage caused by cigarette smoking, blocked 
lesion progress in patients with oral mucosa 
leukoplakia [79] 
GTE Phase II randomized, placebo 
controlled clinical trial in high risk 
oral premalignant lesions (OPLs) 
500 mg/m
2
, 750 mg/m
2
, and 1 g/m
2
. Oral administration. 
3 months. 11 controls and 30 patients with oral 
premalignant lesions. 
Suppress OPLs, in part through reducing 
angiogenic stimulus (stromal VEGF) [78] 
Isoflavones, 
anthocyanidins, 
flavan-3-ols, flavanones, 
flavones, and flavonols 
Case-control study about oral and 
pharyngeal cancer risk 
24.8 µg isoflavones, 21.9 mg anthocyanidins, 65.4 mg 
flavan-3-ols, 38.8 mg flavanones, 0.5 mg flavones,  
22.5 mg flavonols, and 149.2 mg total flavonoids.  
Diet. 13 years. 2081 controls and 805 patients. 
Decreasing the probability to develop oral and 
pharyngeal cancers by 50% [81] 
Green tea Prospective, large-scale cohort study 1–5 cups/day. Drinking water. 10.3 years.  
65,184 subjects. 
Reduced the hazard ratios (HRs) of oral cancer 
in women [82] 
Green tea Pilot intervention study with heavy 
smokers 
400–500 mg/cup, 5 cups/day. Drinking water. 4 weeks.  
3 control, 3 patients. 
Inducing cell growth arrest and apoptosis [77] 
Black tea Clinical Trial in patients with oral 
leukoplakia 
3 teaspoon s/day. Drinking water. 1 year. 82 patients with 
precancerous lesion. 
Decreasing micronuclei frequency and 
chromosomal aberrations [80] 
Mixed green tea Double-blind intervention trial 
performed in patients with oral 
mucosa leukoplakia 
3 g/day. Oral administration. 6 months. 30 control,  
29 oral mucosa leukoplakia. 
Reducing oral leukoplakia in size, inhibiting 
cell micronucleated exfoliation [76] 
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Furthermore, the relation between dietary polyphenols and the risk of oral cancer was also 
investigated by some epidemiologic studies. An Italian case-control study has been conducted to 
examine the relationship between flavonoid intake to oral and pharyngeal cancer risk from 1992 to 
2005 [81]. This study included 805 cases confirmed with oral and pharyngeal cancer, and 2081 hospital 
controls were admitted for non-neoplastic conditions. Results have shown that a high dietary flavonoid 
intake decreased the probability of developing oral and pharyngeal cancers by about 50% [81]. 
Ide et al. [82] conducted a prospective nationwide, large-scale cohort study in Japan including 
20,550 men and 29,671 women aged 40–79 years without any history of oral cancer. After an average of 
10.3 years follow-up period, tea consumption group showed chemo-preventive effects in women 
according to the reduction of hazard ratios of oral cancer when increasing green tea dietary 
administration per day. However, no such trends were identified in men [82]. 
6. Conclusions 
This review summarizes the preventive and possible therapeutic properties of dietary polyphenols 
against oral cancer in vitro, in vivo, and in clinical studies. Oral cancer is one of the most important 
medical problems. Chemopreventive strategies represent a promising approach to reduce the incidence 
and mortality of this disease. Most studies have demonstrated that dietary polyphenols could  
regulate numerous molecular pathways involved in cancer promotion and progression, suggesting 
chemopreventive and therapeutic capacity of dietary polyphenols against oral cancers. Among all 
polyphenols investigated, tea polyphenols have been shown to have obvious anti-carcinogenic effects. 
Limited investigations of other dietary polyphenols have been conducted in spite of their diversity and 
rich sources. Scientific evidences on other dietary polyphenols should be demonstrated to clarify the 
potentials of these molecules on prevention of oral cancer. Compared to a large amount of in vitro and 
animal studies, only a few clinical trials have been performed. Additional randomized clinical trials and 
cohort studies should be conducted to obtain direct evidence of dietary polyphenols against oral cancers. 
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